RARA and acute myeloid leukemia: The retinoic acid receptor-α agonist SY-1425 can promote the differentiation of acute myeloid leukemia cells with high expression of RARA or IRF8 genes, thereby inhibiting tumor growth (McKeown et al., 2019).